z-logo
Premium
Response to Letter: ‘Reply to “High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability?”’
Author(s) -
Pineton de Chambrun M.,
Frere C.,
Miyara M.,
Amoura Z.,
MartinToutain I.,
Mathian A.,
Hekimian G.,
Combes A.
Publication year - 2021
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.13166
Subject(s) - medicine , covid-19 , critically ill , antiphospholipid syndrome , intensive care medicine , critical illness , antibody , betacoronavirus , immunology , virology , disease , infectious disease (medical specialty) , outbreak
Click here to view the Letter to the Editor by Pineton de Chambrun et al.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here